Alerts will be sent to your verified email
Verify EmailHESTERBIO
Hester Biosciences
|
Bajaj Healthcare
|
Themis Medicare
|
|
---|---|---|---|
Operational Metrics
|
|||
Pharmaceutical Sector
|
|||
R&D as a % of Total Sales
|
1.53 % | 0.35 % | 3.59 % |
Financials
|
|||
5 yr Average ROE
|
12.14 % | 9.93 % | 16.7 % |
5yr average Equity Multiplier
|
2.11 | 2.26 | 1.64 |
5yr Average Asset Turnover Ratio
|
0.45 | 0.95 | 0.69 |
5yr Avg Net Profit Margin
|
12.98 % | 3.65 % | 14.74 % |
Price to Book
|
4.94 | 3.66 | 2.85 |
P/E
|
47.88 | 0.0 | 25.43 |
5yr Avg Cash Conversion Cycle
|
83.43 Days | 15.4 Days | 83.02 Days |
Inventory Days
|
106.53 Days | 51.52 Days | 75.24 Days |
Days Receivable
|
94.77 Days | 72.17 Days | 154.39 Days |
Days Payable
|
142.53 Days | 83.01 Days | 149.43 Days |
5yr Average Interest Coverage Ratio
|
7.46 | 7.11 | 6.9 |
5yr Avg ROCE
|
12.53 % | 24.2 % | 18.52 % |
5yr Avg Operating Profit Margin
|
24.84 % | 16.67 % | 19.18 % |
5 yr average Debt to Equity
|
0.74 | 0.86 | 0.34 |
5yr CAGR Net Profit
|
-8.32 % | n/a | 11.92 % |
5yr Average Return on Assets
|
5.95 % | 5.32 % | 10.34 % |
Shareholdings
|
|||
Promoter Holding
|
53.73 % | 59.19 % | 67.15 % |
Share Pledged by Promoters
|
0.0 | 0.0 | 2.43 % |
Change in Promoter Holding (3 Yrs)
|
0.0 | -8.07 % | -0.03 % |
Change in Mutual Fund Holding (3 Yrs)
|
-0.03 % | 1.64 % | 0.0 |
Hester Biosciences
|
Bajaj Healthcare
|
Themis Medicare
|
|
---|---|---|---|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Distribution Channel
|
Distribution Channel
|
-
|
-
|
Operating Profit Break-Up
|
Operating Profit Break-Up
|
Operating Profit Break-Up
|
-
|
Capex
|
Capex
|
-
|
-
|
Asset Break-Up
|
Asset Break-Up
|
Asset Break-Up
|
-
|